Cargando…

Modelling the evolution of drug resistance in the presence of antiviral drugs

BACKGROUND: The emergence of drug resistance in treated populations and the transmission of drug resistant strains to newly infected individuals are important public health concerns in the prevention and control of infectious diseases such as HIV and influenza. Mathematical modelling may help guide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jianhong, Yan, Ping, Archibald, Chris
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2148062/ https://www.ncbi.nlm.nih.gov/pubmed/17953775 http://dx.doi.org/10.1186/1471-2458-7-300

Ejemplares similares

Metabolomics to Predict Antiviral Drug Efficacy in COVID-19
por: Migaud, Marie, et al.
Publicado: (2020)

Host-targeting oral antiviral drugs to prevent pandemics
por: Dwek, Raymond A, et al.
Publicado: (2022)

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
por: Takashita, Emi, et al.
Publicado: (2022)

Monkeypox treatment options: current status of antiviral drugs – a correspondence
por: Ganapthy, Dhanraj, et al.
Publicado: (2023)

Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects
por: Chakraborty, Sandip, et al.
Publicado: (2022)

Antiviral drug resistance /
Publicado: (1996)

The way forward for drug-resistant tuberculosis in the Philippines
por: Bernardo, Madeleine Nicole G, et al.
Publicado: (2022)

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
por: Takashita, Emi, et al.
Publicado: (2022)

Association between drug resistance & production of biofilm in staphylococci
por: Agarwal, Astha, et al.
Publicado: (2012)

Lichenoid Drug Eruption Progressing into Erythroderma in A Case of Cervical Scrofuloderma Due to Multi Drug-Resistant Tuberculosis
por: Kura, Mahendra M, et al.
Publicado: (2022)

Antiviral drug resistance as an adaptive process
por: Irwin, Kristen K., et al.
Publicado: (2016)

Cost-Effective Control of Drug-Resistant TB: Listening to Other Voices
por: Portero, Jose Luis, et al.
Publicado: (2006)

Drug resistance mutations among people living with HIV with treatment failure in Henan Province, China
por: Liu, Jinjin, et al.
Publicado: (2023)

Artificial intelligence (AI) is paving the way for a critical role in drug discovery, drug design, and studying drug–drug interactions – correspondence
por: Chakraborty, Sandip, et al.
Publicado: (2023)

Adverse drug reactions of nonsteroidal anti-inflammatory drugs
por: Wiwanitkit, Viroj
Publicado: (2011)

Emergence of multi drug resistant bacteria in diabetic patients with lower limb wounds
por: Xavier, Wilbin, et al.
Publicado: (2014)

Drug resistance in Enterococcus species in a tertiary level hospital in Assam, India
por: Barman, Jahnabi, et al.
Publicado: (2016)

Indigenous Drugs
Publicado: (1880)

A user-friendly mathematical modelling web interface to assist local decision making in the fight against drug-resistant tuberculosis
por: Ragonnet, Romain, et al.
Publicado: (2017)

A model for the emergence of drug resistance in the presence of asymptomatic infections
por: Robinson, Marguerite, et al.
Publicado: (2013)

Antiviral effects of oleandrin
por: Newman, R., et al.
Publicado: (2021)

Advances in targeted drugs for allergic diseases
por: Wang, Xue-Song, et al.
Publicado: (2021)

Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland
por: Tibble, Holly, et al.
Publicado: (2023)

Repeated prescription of known identified drugs with a history of drug allergy
por: Wiwanitkit, Viroj
Publicado: (2011)

Hepatitis C Virus and Antiviral Drug Resistance
por: Kim, Seungtaek, et al.
Publicado: (2016)

Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drug
por: Jain, Nirmal Kumar
Publicado: (2022)

Antiviral Drugs
por: Vardanyan, Ruben, et al.
Publicado: (2016)

Antiviral drugs
por: Koch, Oliver, et al.
Publicado: (2010)

Antiviral drugs
por: Samuel, Essie, et al.
Publicado: (2022)

Indigenous Indian Drugs
por: Ghosh, J. C.
Publicado: (1925)

Sulpha and Sulphone Drugs
por: Basu, U. P.
Publicado: (1950)

The Food and Drugs Act
por: Hirst, A. Norman
Publicado: (1911)

The Drug Control Bill
por: Lahiri, J. N.
Publicado: (1938)

Hospitals and Dangerous Drugs
por: Holderness, E. W. E.
Publicado: (1924)

Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
por: Dekkers, Bart G.J., et al.
Publicado: (2019)

Structures and mechanism of chitin synthase and its inhibition by antifungal drug Nikkomycin Z
por: Wu, Yanan, et al.
Publicado: (2022)

Drug Patch Testing in Patients of Fixed Drug Reaction Due to Fluoroquinolones-Imidazole Combination
por: Rathi, Shivani, et al.
Publicado: (2022)

Misuse of Pirated Drugs: Why China? What Is Next?
por: Sun, Hui-wen, et al.
Publicado: (2016)

Comparison of line probe assay with liquid culture for rapid detection of multi-drug resistance in Mycobacterium tuberculosis
por: Singhal, Ritu, et al.
Publicado: (2012)

Multi-drug resistance in clinical isolates of Gram-negative bacilli in a tertiary care hospital of Assam
por: Dutta, Himadri, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dshqembano2es4ihqk8p6qvebj